Illustration shows GSK (GlaxoSmithKline) logo GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Post navigation Previous: GSK soothes investors by settling first Zantac cancer lawsuit due for US trial